Developing anti-Müllerian hormone as an ovarian reserve biomarker
{{output}}
The first anti-Müllerian hormone (AMH) radioimmunoassay became available for clinical use in the early 2000s. This MHR Legacy Series review discusses key contributions from our own group towards establishing AMH as a robust ovarian reserve biomarker. Initial ... ...
